QCM
VNDA icon

Quantinno Capital Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Quantinno Capital Management’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.92M Sell
313,788
-13,405
-4% -$87.6K ﹤0.01% 2003
2026
Q1 		$2.26M Buy
327,193
+65,391
+25% +$504K ﹤0.01% 1538
2025
Q4 		$2.31M Buy
261,802
+179,504
+218% +$988K ﹤0.01% 1313
2025
Q3 		$411K Buy
82,298
+63,836
+346% +$296K ﹤0.01% 2190
2025
Q2 		$87.1K Sell
18,462
-2,403
-12% -$10.5K ﹤0.01% 2527
2025
Q1 		$95.8K Buy
20,865
+10,853
+108% +$50.6K ﹤0.01% 2037
2024
Q4 		$48K Buy
+10,012
New +$48.1K ﹤0.01% 1641

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Quantinno Capital Management's VNDA Position: Q2 2026 in Review

Quantinno Capital Management reduced its Vanda Pharmaceuticals (VNDA) stake by 4.1% in Q2 2026, selling an estimated $87.6K and leaving 313,788 shares worth $1.92M. The position accounts for ﹤0.01% of the portfolio, ranked #2003.

Quantinno Capital Management first reported a position in VNDA in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.31M in Q4 2025. 172 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

  • Quantinno Capital Management held 313,788 shares of Vanda Pharmaceuticals worth $1.92M as of Q2 2026.
  • Quantinno Capital Management sold 13,405 Vanda Pharmaceuticals shares in Q2 2026, an estimated $87.6K.
  • Vanda Pharmaceuticals made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #2003 holding.
  • Quantinno Capital Management first reported a position in Vanda Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • Quantinno Capital Management's Vanda Pharmaceuticals position peaked at $2.31M in Q4 2025.
  • 172 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.